No hearing loss after repeated courses of tobramycin in cystic fibrosis patients

Author： Scheenstra Renske J.   Heijerman Harry G.M.   Zuur Charlotte L.   Touw Daan J.   Rijntjes Evert  

Publisher： Informa Healthcare

ISSN： 0001-6489

Source： Acta Oto-Laryngologica, Vol.130, Iss.2, 2010-02, pp. : 253-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Factors for Hearing Loss in Patients with Cystic Fibrosis

By Tarshish Yael   Huang Lin   Jackson Frank I.   Edwards Julianne   Fligor Brian   Wilkins Abigail   Uluer Ahmet   Sawicki Gregory   Kenna Margaret  

Journal of the American Academy of Audiology, Vol. 27, Iss. 1, 2016-01 ,pp. : 6-12

American Academy of Audiology

Access to resources Recommend Favorite

Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients

By Scheenstra Renske   Rijntjes Evert   Tavy Denes   Kingma Herman   Heijerman Harry  

Acta Oto-Laryngologica, Vol. 129, Iss. 1, 2009-01 ,pp. : 4-7

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Courses of Hearing Loss in Young Children

By  

ORL, Vol. 71, Iss. 1, 2010-02 ,pp. : 74-77

Karger

Access to resources Recommend Favorite

Presence of Fungus in Sinus Cultures of Cystic Fibrosis Patients

By Wise Sarah K.   Kingdom Todd T.   McKean Lawrence   DelGaudio John M.   Venkatraman Giridhar  

American Journal of Rhinology, Vol. 19, Iss. 1, 2005-01 ,pp. : 47-51

OceanSide Publications, Inc

Access to resources Recommend Favorite

Hearing loss after "refractory" secretory otitis media

By Ryding Marie   Konradsson Konrad   White Peter   Kalm Olof  

Acta Oto-Laryngologica, Vol. 125, Iss. 3, 2005-03 ,pp. : 250-255

Informa Healthcare

Access to resources Recommend Favorite